These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 18430787

  • 1. Synthetic oligonucleotides as modulators of inflammation.
    Klinman D, Shirota H, Tross D, Sato T, Klaschik S.
    J Leukoc Biol; 2008 Oct; 84(4):958-64. PubMed ID: 18430787
    [Abstract] [Full Text] [Related]

  • 2. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection.
    Klinman DM, Conover J, Coban C.
    Infect Immun; 1999 Nov; 67(11):5658-63. PubMed ID: 10531213
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides.
    Klinman DM, Tross D, Klaschik S, Shirota H, Sato T.
    Ann N Y Acad Sci; 2009 Sep; 1175():80-8. PubMed ID: 19796080
    [Abstract] [Full Text] [Related]

  • 4. An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems.
    Ho PP, Fontoura P, Ruiz PJ, Steinman L, Garren H.
    J Immunol; 2003 Nov 01; 171(9):4920-6. PubMed ID: 14568974
    [Abstract] [Full Text] [Related]

  • 5. Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants.
    Klinman DM, Klaschik S, Tomaru K, Shirota H, Tross D, Ikeuchi H.
    Vaccine; 2010 Feb 23; 28(8):1919-23. PubMed ID: 20188247
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.
    Klinman DM, Klaschik S, Sato T, Tross D.
    Adv Drug Deliv Rev; 2009 Mar 28; 61(3):248-55. PubMed ID: 19272313
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides.
    Weiner GJ.
    J Leukoc Biol; 2000 Oct 28; 68(4):455-63. PubMed ID: 11037965
    [Abstract] [Full Text] [Related]

  • 12. Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.
    Yu C, An M, Jones E, Liu H.
    Pharm Res; 2018 Feb 08; 35(3):56. PubMed ID: 29423660
    [Abstract] [Full Text] [Related]

  • 13. Suppressive oligodeoxynucleotides inhibit CpG-induced inflammation of the mouse lung.
    Yamada H, Ishii KJ, Klinman DM.
    Crit Care Med; 2004 Oct 08; 32(10):2045-9. PubMed ID: 15483413
    [Abstract] [Full Text] [Related]

  • 14. Structure, mechanism and therapeutic utility of immunosuppressive oligonucleotides.
    Bayik D, Gursel I, Klinman DM.
    Pharmacol Res; 2016 Mar 08; 105():216-25. PubMed ID: 26779666
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
    Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV.
    Infect Immun; 2000 Mar 08; 68(3):1450-6. PubMed ID: 10678959
    [Abstract] [Full Text] [Related]

  • 17. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.
    Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, Bals R, Giese T, Engelmann H, Endres S, Krieg AM, Hartmann G.
    Eur J Immunol; 2001 Oct 08; 31(10):3026-37. PubMed ID: 11592079
    [Abstract] [Full Text] [Related]

  • 18. Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock.
    Shirota H, Gursel I, Gursel M, Klinman DM.
    J Immunol; 2005 Apr 15; 174(8):4579-83. PubMed ID: 15814679
    [Abstract] [Full Text] [Related]

  • 19. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells.
    Britigan BE, Lewis TS, Waldschmidt M, McCormick ML, Krieg AM.
    J Immunol; 2001 Sep 01; 167(5):2921-8. PubMed ID: 11509640
    [Abstract] [Full Text] [Related]

  • 20. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif.
    Zhang Y, Shoda LK, Brayton KA, Estes DM, Palmer GH, Brown WC.
    J Interferon Cytokine Res; 2001 Oct 01; 21(10):871-81. PubMed ID: 11711000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.